Previous studies established an association between TSH levels and MASLD [9,10,11]; this association appears to persist even when considering subclinical hypothyroidism or TSH levels in the upper normal range [12], suggesting the role of TSH in MASLD independently of thyroid hormone levels. This evidence concerns the gene TG and metabolic dysfunction-associated steatotic liver disease.